Company intelligence / Profile preview
Sunshine Biopharma Inc.
Fort Lauderdale, Florida, United Statessunshinebiopharma.com ↗
- Ownership
- Public · SBFM
- Employees
- ~44
- Development stage
- Other
01
Overview
The company has approximately 70 generic prescription drugs on the market in Canada while developing proprietary candidates including K1.1 mRNA for liver cancer, Adva-27a for pancreatic cancer, and PLpro inhibitors for COVID-19.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculesmRNA
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
University of ArizonaUniversity of Illinois Chicago
04
Financials
- Market cap
- $5.9M
- Total revenue
- $36.3M
- Enterprise value
- $-7.1M
Beyond the preview
Go deeper on Sunshine Biopharma Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sunshine Biopharma Inc..